Prokarium

London, United Kingdom · Founded 2012 · Privately Held (backing)

Operator of a biopharmaceutical company intended for developing bacterial immunotherapies for cancer. Prokarium is based in London, United Kingdom and was founded in 2012. Its last reported valuation was $109 million in Feb 2023. It has raised $88.8 million.

Last reported valuation
$109.4M
Oct 2026
Priced at
—
Total raised
$88.8M
Last round
—

Who backs Prokarium?

12 investors
InvestorType
Innovate UKOther
Korea Investment PartnersVenture capital
London & Partners.Other
British Business BankOther
Wellcome TrustOther
Ginkgo BioworksOther
Biotechnology and Biological Sciences Research CouncilOther
Riyadh Valley CompanyOther
Conahcyt—
Flerie—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Prokarium investors

12 investors are on record for Prokarium, including Innovate UK, Korea Investment Partners, London & Partners. and British Business Bank.

Free account
More of Prokarium with a free account
  • ·The complete investor list: 12 names
  • ·Watch Prokarium: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like Prokarium. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View